Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.

Melchior B, Mittapalli GK, Lai C, Duong-Polk K, Stewart J, Güner B, Hofilena B, Tjitro A, Anderson SD, Herman DS, Dellamary L, Swearingen CJ, Sunil KC, Yazici Y.

Aging Cell. 2019 Jul 3:e13000. doi: 10.1111/acel.13000. [Epub ahead of print]

2.

Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.

Stein MD, Conti MT, Herman DS, Anderson BJ, Bailey GL, Noppen DV, Abrantes AM.

Am J Addict. 2019 Jul;28(4):270-276. doi: 10.1111/ajad.12884. Epub 2019 Apr 16.

PMID:
30993833
3.

Emerging Adults' Discussion of Substance Use and Sexual Behavior with Providers.

Blevins CE, Anderson BJ, Caviness CM, Herman DS, Stein MD.

J Health Commun. 2019;24(2):121-128. doi: 10.1080/10810730.2019.1583700. Epub 2019 Feb 26.

PMID:
30806172
4.

A longitudinal evaluation of the role of alcohol self-concept in alcohol use, motives, negative affect, and alcohol-related problems among emerging adults.

Blevins CE, Abrantes AM, Anderson BJ, Caviness CM, Herman DS, Stein MD.

Am J Addict. 2018 Sep;27(6):501-508. doi: 10.1111/ajad.12768. Epub 2018 Jul 24.

PMID:
30039892
5.

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Horvat C, Johnson R, Lam L, Munro J, Mazzarotto F, Roberts AM, Herman DS, Parfenov M, Haghighi A, McDonough B, DePalma SR, Keogh AM, Macdonald PS, Hayward CS, Roberts A, Barton PJR, Felkin LE, Giannoulatou E, Cook SA, Seidman JG, Seidman CE, Fatkin D.

Genet Med. 2019 Jan;21(1):133-143. doi: 10.1038/s41436-018-0036-2. Epub 2018 Jun 11.

PMID:
29892087
6.

Quality Control Practices for Chemistry and Immunochemistry in a Cohort of 21 Large Academic Medical Centers.

Rosenbaum MW, Flood JG, Melanson SEF, Baumann NA, Marzinke MA, Rai AJ, Hayden J, Wu AHB, Ladror M, Lifshitz MS, Scott MG, Peck-Palmer OM, Bowen R, Babic N, Sobhani K, Giacherio D, Bocsi GT, Herman DS, Wang P, Toffaletti J, Handel E, Kelly KA, Albeiroti S, Wang S, Zimmer M, Driver B, Yi X, Wilburn C, Lewandrowski KB.

Am J Clin Pathol. 2018 Jul 3;150(2):96-104. doi: 10.1093/ajcp/aqy033.

PMID:
29850771
7.

Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog.

Herman DS, Smith C, Liu C, Vaughn CP, Palaniappan S, Pritchard CC, Shirts BH.

J Mol Diagn. 2018 Jul;20(4):512-521. doi: 10.1016/j.jmoldx.2018.03.010. Epub 2018 May 22.

8.

Identity as a cannabis user is related to problematic patterns of consumption among emerging adults.

Blevins CE, Abrantes AM, Anderson BJ, Caviness CM, Herman DS, Stein MD.

Addict Behav. 2018 Apr;79:138-143. doi: 10.1016/j.addbeh.2017.12.021. Epub 2017 Dec 20.

9.

Variability and Error in Cardiac Troponin Testing: An ACLPS Critical Review.

Herman DS, Kavsak PA, Greene DN.

Am J Clin Pathol. 2017 Oct 1;148(4):281-295. doi: 10.1093/ajcp/aqx066. Review.

PMID:
28967956
10.

The overlap of sleep disturbance and depression in primary care patients treated with buprenorphine.

Garnaat SL, Weisberg RB, Uebelacker LA, Herman DS, Bailey GL, Anderson BJ, Sharkey KM, Stein MD.

Subst Abus. 2017 Oct-Dec;38(4):450-454. doi: 10.1080/08897077.2017.1361498. Epub 2017 Sep 13.

PMID:
28901836
11.

A developmental-based motivational intervention to reduce alcohol and marijuana use among non-treatment-seeking young adults: a randomized controlled trial.

Stein MD, Caviness CM, Morse EF, Grimone KR, Audet D, Herman DS, Moitra E, Anderson BJ.

Addiction. 2018 Mar;113(3):440-453. doi: 10.1111/add.14026. Epub 2017 Oct 16.

12.

Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.

Phillips KT, Anderson BJ, Herman DS, Liebschutz JM, Stein MD.

J Addict Med. 2017 Nov/Dec;11(6):461-467. doi: 10.1097/ADM.0000000000000346.

13.

Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.

Safren SA, Bedoya CA, O'Cleirigh C, Biello KB, Pinkston MM, Stein MD, Traeger L, Kojic E, Robbins GK, Lerner JA, Herman DS, Mimiaga MJ, Mayer KH.

Lancet HIV. 2016 Nov;3(11):e529-e538. doi: 10.1016/S2352-3018(16)30053-4. Epub 2016 Sep 19.

14.

Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification.

Herman DS, Ranjitkar P, Yamaguchi D, Grenache DG, Greene DN.

Clin Biochem. 2016 Oct;49(15):1118-1121. doi: 10.1016/j.clinbiochem.2016.06.006. Epub 2016 Jun 16.

PMID:
27317886
15.

Pilot Randomized Trial of Collaborative Behavioral Treatment for Chronic Pain and Depression in Persons Living with HIV/AIDS.

Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Garnaat SL, Stein MD.

AIDS Behav. 2016 Aug;20(8):1675-81. doi: 10.1007/s10461-016-1397-7.

16.

Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD.

Pain Med. 2015 Oct;16(10):1870-81. doi: 10.1111/pme.12799. Epub 2015 Jun 27.

17.

Chronic pain and depression among primary care patients treated with buprenorphine.

Stein MD, Herman DS, Bailey GL, Straus J, Anderson BJ, Uebelacker LA, Weisberg RB.

J Gen Intern Med. 2015 Jul;30(7):935-41. doi: 10.1007/s11606-015-3212-y. Epub 2015 Feb 13.

18.

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.

Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, Murray ML, Tokita MJ, Gallego CJ, Kim DS, Bennett JT, Crosslin DR, Ranchalis J, Jones KL, Rosenthal EA, Jarvik ER, Itsara A, Turner EH, Herman DS, Schleit J, Burt A, Jamal SM, Abrudan JL, Johnson AD, Conlin LK, Dulik MC, Santani A, Metterville DR, Kelly M, Foreman AK, Lee K, Taylor KD, Guo X, Crooks K, Kiedrowski LA, Raffel LJ, Gordon O, Machini K, Desnick RJ, Biesecker LG, Lubitz SA, Mulchandani S, Cooper GM, Joffe S, Richards CS, Yang Y, Rotter JI, Rich SS, O'Donnell CJ, Berg JS, Spinner NB, Evans JP, Fullerton SM, Leppig KA, Bennett RL, Bird T, Sybert VP, Grady WM, Tabor HK, Kim JH, Bamshad MJ, Wilfond B, Motulsky AG, Scott CR, Pritchard CC, Walsh TD, Burke W, Raskind WH, Byers P, Hisama FM, Rehm H, Nickerson DA, Jarvik GP.

Genome Res. 2015 Mar;25(3):305-15. doi: 10.1101/gr.183483.114. Epub 2015 Jan 30.

19.

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, Mazzarotto F, Felkin LE, Gong S, MacArthur JA, Cunningham F, Flannick J, Gabriel SB, Altshuler DM, Macdonald PS, Heinig M, Keogh AM, Hayward CS, Banner NR, Pennell DJ, O'Regan DP, San TR, de Marvao A, Dawes TJ, Gulati A, Birks EJ, Yacoub MH, Radke M, Gotthardt M, Wilson JG, O'Donnell CJ, Prasad SK, Barton PJ, Fatkin D, Hubner N, Seidman JG, Seidman CE, Cook SA.

Sci Transl Med. 2015 Jan 14;7(270):270ra6. doi: 10.1126/scitranslmed.3010134.

20.

A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine.

Stein MD, Herman DS, Moitra E, Hecht J, Lopez R, Anderson BJ, Brown RA.

Drug Alcohol Depend. 2015 Feb 1;147:243-50. doi: 10.1016/j.drugalcdep.2014.11.007. Epub 2014 Nov 26.

21.

A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes.

Brown RA, Bloom EL, Hecht J, Moitra E, Herman DS, Stein MD.

Behav Modif. 2014 Sep;38(5):730-59. doi: 10.1177/0145445514538279. Epub 2014 Jun 27.

22.

5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.

Christodoulou DC, Wakimoto H, Onoue K, Eminaga S, Gorham JM, DePalma SR, Herman DS, Teekakirikul P, Conner DA, McKean DM, Domenighetti AA, Aboukhalil A, Chang S, Srivastava G, McDonough B, De Jager PL, Chen J, Bulyk ML, Muehlschlegel JD, Seidman CE, Seidman JG.

J Clin Invest. 2014 Mar;124(3):1364-70. doi: 10.1172/JCI70108. Epub 2014 Feb 10.

23.

Days of heroin use predict poor self-reported health in hospitalized heroin users.

Meshesha LZ, Tsui JI, Liebschutz JM, Crooks D, Anderson BJ, Herman DS, Stein MD.

Addict Behav. 2013 Dec;38(12):2884-7. doi: 10.1016/j.addbeh.2013.08.002. Epub 2013 Aug 14.

24.

Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.

Bailey GL, Herman DS, Stein MD.

J Subst Abuse Treat. 2013 Sep;45(3):302-5. doi: 10.1016/j.jsat.2013.04.002. Epub 2013 Jun 18.

25.

Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.

Bick AG, Flannick J, Ito K, Cheng S, Vasan RS, Parfenov MG, Herman DS, DePalma SR, Gupta N, Gabriel SB, Funke BH, Rehm HL, Benjamin EJ, Aragam J, Taylor HA Jr, Fox ER, Newton-Cheh C, Kathiresan S, O'Donnell CJ, Wilson JG, Altshuler DM, Hirschhorn JN, Seidman JG, Seidman C.

Am J Hum Genet. 2012 Sep 7;91(3):513-9. doi: 10.1016/j.ajhg.2012.07.017.

26.

Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.

Strong DR, Brown RA, Sims M, Herman DS, Anderson BJ, Stein MD.

J Addict Med. 2012 Sep;6(3):219-25. doi: 10.1097/ADM.0b013e31825d927f.

27.

Truncations of titin causing dilated cardiomyopathy.

Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE.

N Engl J Med. 2012 Feb 16;366(7):619-28. doi: 10.1056/NEJMoa1110186.

28.

Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.

Holleboom AG, Karlsson H, Lin RS, Beres TM, Sierts JA, Herman DS, Stroes ES, Aerts JM, Kastelein JJ, Motazacker MM, Dallinga-Thie GM, Levels JH, Zwinderman AH, Seidman JG, Seidman CE, Ljunggren S, Lefeber DJ, Morava E, Wevers RA, Fritz TA, Tabak LA, Lindahl M, Hovingh GK, Kuivenhoven JA.

Cell Metab. 2011 Dec 7;14(6):811-8. doi: 10.1016/j.cmet.2011.11.005.

29.

Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.

Marshall TM, Herman DS, Largent-Milnes TM, Badghisi H, Zuber K, Holt SC, Lai J, Porreca F, Vanderah TW.

Pain. 2012 Jan;153(1):86-94. doi: 10.1016/j.pain.2011.09.021. Epub 2011 Oct 24.

30.

Genome-wide assessment for genetic variants associated with ventricular dysfunction after primary coronary artery bypass graft surgery.

Fox AA, Pretorius M, Liu KY, Collard CD, Perry TE, Shernan SK, De Jager PL, Hafler DA, Herman DS, DePalma SR, Roden DM, Muehlschlegel JD, Donahue BS, Darbar D, Seidman JG, Body SC, Seidman CE.

PLoS One. 2011;6(9):e24593. doi: 10.1371/journal.pone.0024593. Epub 2011 Sep 30.

31.

Motivational and mindfulness intervention for young adult female marijuana users.

de Dios MA, Herman DS, Britton WB, Hagerty CE, Anderson BJ, Stein MD.

J Subst Abuse Treat. 2012 Jan;42(1):56-64. doi: 10.1016/j.jsat.2011.08.001. Epub 2011 Sep 21.

32.

Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms.

Tsui JI, Herman DS, Kettavong M, Anderson BJ, Stein MD.

Pain. 2011 Nov;152(11):2640-4. doi: 10.1016/j.pain.2011.08.011. Epub 2011 Sep 15.

33.

Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain.

Hanlon KE, Herman DS, Agnes RS, Largent-Milnes TM, Kumarasinghe IR, Ma SW, Guo W, Lee YS, Ossipov MH, Hruby VJ, Lai J, Porreca F, Vanderah TW.

Brain Res. 2011 Jun 13;1395:1-11. doi: 10.1016/j.brainres.2011.04.024. Epub 2011 Apr 20.

34.

Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.

Tsui JI, Herman DS, Kettavong M, Anderson BJ, Stein MD.

J Addict Dis. 2011 Apr;30(2):91-7. doi: 10.1080/10550887.2011.554775.

35.

Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease.

Christodoulou DC, Gorham JM, Herman DS, Seidman JG.

Curr Protoc Mol Biol. 2011 Apr;Chapter 4:Unit4.12. doi: 10.1002/0471142727.mb0412s94.

36.

Quantification of gene transcripts with deep sequencing analysis of gene expression (DSAGE) using 1 to 2 µg total RNA.

Christodoulou DC, Gorham JM, Kawana M, DePalma SR, Herman DS, Wakimoto H.

Curr Protoc Mol Biol. 2011 Jan;Chapter 25:Unit25B.9. doi: 10.1002/0471142727.mb25b09s93.

37.

Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: an application of the acquired preparedness model.

Hayaki J, Herman DS, Hagerty CE, de Dios MA, Anderson BJ, Stein MD.

Addict Behav. 2011 Apr;36(4):389-96. doi: 10.1016/j.addbeh.2010.12.018. Epub 2010 Dec 21.

38.

A brief marijuana intervention for non-treatment-seeking young adult women.

Stein MD, Hagerty CE, Herman DS, Phipps MG, Anderson BJ.

J Subst Abuse Treat. 2011 Mar;40(2):189-98. doi: 10.1016/j.jsat.2010.11.001. Epub 2010 Dec 24.

39.

Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms.

Tsui JI, Herman DS, Kettavong M, Alford D, Anderson BJ, Stein MD.

J Subst Abuse Treat. 2010 Dec;39(4):378-83. doi: 10.1016/j.jsat.2010.06.012. Epub 2010 Aug 19.

40.

General anxiety disorder symptoms, tension reduction, and marijuana use among young adult females.

de Dios MA, Hagerty CE, Herman DS, Hayaki J, Anderson BJ, Budney AJ, Stein M.

J Womens Health (Larchmt). 2010 Sep;19(9):1635-42. doi: 10.1089/jwh.2010.1973.

41.

Expectancies and marijuana use frequency and severity among young females.

Hayaki J, Hagerty CE, Herman DS, de Dios MA, Anderson BJ, Stein MD.

Addict Behav. 2010 Nov;35(11):995-1000. doi: 10.1016/j.addbeh.2010.06.017. Epub 2010 Jun 25.

42.

Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ.

J Subst Abuse Treat. 2010 Sep;39(2):157-66. doi: 10.1016/j.jsat.2010.05.014. Epub 2010 Jul 3.

43.

Marijuana use subtypes in a community sample of young adult women.

de Dios MA, Anderson BJ, Herman DS, Hagerty CE, Caviness CM, Budney AJ, Stein M.

Womens Health Issues. 2010 May-Jun;20(3):201-10. doi: 10.1016/j.whi.2010.02.001.

44.

A trial to reduce hepatitis C seroincidence in drug users.

Stein MD, Herman DS, Anderson BJ.

J Addict Dis. 2009 Oct;28(4):389-98. doi: 10.1080/10550880903183034.

45.

Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery.

Body SC, Collard CD, Shernan SK, Fox AA, Liu KY, Ritchie MD, Perry TE, Muehlschlegel JD, Aranki S, Donahue BS, Pretorius M, Estrada JC, Ellinor PT, Newton-Cheh C, Seidman CE, Seidman JG, Herman DS, Lichtner P, Meitinger T, Pfeufer A, Kääb S, Brown NJ, Roden DM, Darbar D.

Circ Cardiovasc Genet. 2009 Oct;2(5):499-506. doi: 10.1161/CIRCGENETICS.109.849075. Epub 2009 Aug 2.

46.

Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection.

Herman DS, Hovingh GK, Iartchouk O, Rehm HL, Kucherlapati R, Seidman JG, Seidman CE.

Nat Methods. 2009 Jul;6(7):507-10. doi: 10.1038/nmeth.1343. Epub 2009 Jun 21.

47.

MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice.

Sorkin LS, Boyle DL, Hammaker D, Herman DS, Vail E, Firestein GS.

Neuroscience. 2009 Aug 18;162(2):462-71. doi: 10.1016/j.neuroscience.2009.05.008. Epub 2009 May 8.

48.

Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.

Fox AA, Collard CD, Shernan SK, Seidman CE, Seidman JG, Liu KY, Muehlschlegel JD, Perry TE, Aranki SF, Lange C, Herman DS, Meitinger T, Lichtner P, Body SC.

Anesthesiology. 2009 Apr;110(4):738-47.

49.

Influence of minerals on lead-induced alterations in liver function in rats exposed to long-term lead exposure.

Herman DS, Geraldine M, T V.

J Hazard Mater. 2009 Jul 30;166(2-3):1410-4. doi: 10.1016/j.jhazmat.2008.12.070. Epub 2008 Dec 24.

PMID:
19167163
50.

Supplemental Content

Loading ...
Support Center